ADVANCED ENZYME TECHNOLOGIES
Back to All Ratios
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 18.30 | 22.57 | 18.65 | 19.86 | 21.40 |
What is the latest Price to Cash Earnings (PCE) ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 18.30 |
| Mar2024 | 22.57 |
| Mar2023 | 18.65 |
| Mar2022 | 19.86 |
| Mar2021 | 21.40 |
How is Price to Cash Earnings (PCE) of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 18.3 | -18.92 | |
| Mar2024 | 22.57 | 21.02 | |
| Mar2023 | 18.65 | -6.09 | |
| Mar2022 | 19.86 | -7.20 | |
| Mar2021 | 21.4 | - | |
Other Financial Ratios of ADVANCED ENZYME TECHNOLOGIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹4,203.4 Cr | 3.2% | 25.4% | 32% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 3.2% |
25.4% |
32% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses